首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program 1995-2006
【2h】

Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program 1995-2006

机译:在加拿大检测和鉴定不同种类的万古霉素中间金黄色葡萄球菌分离株:1995-2006年加拿大医院感染监测计划的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe the epidemiology of heterogeneously resistant Staphylococcus aureus (hVISA) identified in Canadian hospitals between 1995 and 2006. hVISA isolates were confirmed by the population analysis profiling-area under the curve method. Only 25 hVISA isolates (1.3% of all isolates) were detected. hVISA isolates were more likely to have been health care associated (odds ratio [OR], 5.1; 95% confidence interval [CI], 1.9 to 14.2) and to have been recovered from patients hospitalized in central Canada (OR, 3.0; 95% CI, 1.2 to 7.4). There has been no evidence of vancomycin “MIC creep” in Canadian strains of methicillin (meticillin)-resistant S. aureus, and hVISA strains are currently uncommon.
机译:我们描述了1995年至2006年间在加拿大医院中发现的异种耐药金黄色葡萄球菌(hVISA)的流行病学。hVISA分离株通过曲线分析下的人口分析分布图区域得到确认。仅检测到25个hVISA分离株(占所有分离株的1.3%)。 hVISA分离物更可能与医疗保健相关(比值比[OR],5.1; 95%置信区间[CI],1.9至14.2),并且已从加拿大中部住院的患者中恢复(OR,3.0; 95% CI,1.2至7.4)。在耐甲氧西林(美西林)的金黄色葡萄球菌加拿大菌株中,没有万古霉素“ MIC蠕变”的迹象,而hVISA菌株目前并不常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号